Interestingly, fusion of the ESR1 gene with other genes (like AKAP12, ARMT1 and CCDC170) have been shown to occur even in early BC patients and as the ligand binding domain of ESR1 has been replaced, ER fusion proteins are constitutively active, similar to mutant ER proteins [295]. The gene discussed is ESR1; the disease is breast cancer.